Innovative collagen nano-hydroxyapatite scaffolds offer a highly efficient non-viral gene delivery platform for stem cell-mediated bone formation

Adv Mater. 2012 Feb 7;24(6):749-54. doi: 10.1002/adma.201103828. Epub 2012 Jan 2.

Abstract

The ability of nano-hydroxyapatite (nHA) particles developed in-house to act as non-viral delivery vectors is assessed. These nHA particles are combined with collagen to yield bioactive, biodegradable collagen nano-hydroxyapatite (coll-nHA) scaffolds. Their ability to act as gene-activated matrices for BMP2 delivery is demonstrated with successful transfection of mesenchymal stem cells (MSCs) resulting in high calcium production.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Morphogenetic Proteins / genetics
  • Cell Line
  • Collagen / chemistry
  • Collagen / metabolism*
  • Durapatite / metabolism*
  • Humans
  • Mesenchymal Stem Cells / cytology*
  • Nanomedicine
  • Nanostructures / chemistry*
  • Osteogenesis*
  • Rats
  • Tissue Scaffolds / chemistry*
  • Transfection / methods*

Substances

  • Bone Morphogenetic Proteins
  • Collagen
  • Durapatite